Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Human iPSC-NSC-Derived Extracellular Vesicles Can Alleviate Alzheimer's Disease-Linked Impairments in Mitochondria, mTOR Signaling, Autophagy, and Hippocampal Neurogenesis.

Aging cellĀ·2026
Same author

Post-traumatic stress disorder: pathogenesis, epidemiological characteristics, animal models, and potential therapeutic strategies.

Military Medical ResearchĀ·2026
Same author

Targeting autophagy in lateral habenula for alleviating depression.

Neural regeneration researchĀ·2026
Same author

Intranasal Human NSC-Derived EVs Therapy Can Restrain Inflammatory Microglial Transcriptome, and NLRP3 and cGAS-STING Signalling, in Aged Hippocampus.

Journal of extracellular vesiclesĀ·2026
Same author

Intranasal Human NSC-Derived EVs Therapy Can Restrain Inflammatory Microglial Transcriptome, and NLRP3 and cGAS-STING Signaling, in Aged Hippocampus.

bioRxiv : the preprint server for biologyĀ·2026
Same author

Host-membrane lipid composition controls <i>Cryptococcus neoformans</i> cellular targets.

Frontiers in immunologyĀ·2026

Related Experiment Video

Updated: May 29, 2026

Organotypic Cultures of Adult Human Cortex as an Ex vivo Model for Human Stem Cell Transplantation and Validation
07:16

Organotypic Cultures of Adult Human Cortex as an Ex vivo Model for Human Stem Cell Transplantation and Validation

Published on: December 9, 2022

Progress in cell grafting therapy for temporal lobe epilepsy.

Ashok K Shetty1

  • 1Institute for Regenerative Medicine, Texas A&M Health Science Center at Scott & White, Department of Molecular and Cellular Medicine, Temple, TX 76502, USA. shetty@medicine.tamhsc.edu

Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics
|September 6, 2011
PubMed
Summary

Cell transplantation shows promise for treating temporal lobe epilepsy (TLE) by reducing seizures and improving cognition. Further research in animal models is crucial before clinical application for this challenging neurological disorder.

More Related Videos

Anteromesial Temporal Lobectomy for Medically Intractable Temporal Lobe Epilepsy: An Operative Study
11:29

Anteromesial Temporal Lobectomy for Medically Intractable Temporal Lobe Epilepsy: An Operative Study

Published on: August 15, 2025

Promotion of Survival and Differentiation of Neural Stem Cells with Fibrin and Growth Factor Cocktails after Severe Spinal Cord Injury
09:56

Promotion of Survival and Differentiation of Neural Stem Cells with Fibrin and Growth Factor Cocktails after Severe Spinal Cord Injury

Published on: July 27, 2014

Related Experiment Videos

Last Updated: May 29, 2026

Organotypic Cultures of Adult Human Cortex as an Ex vivo Model for Human Stem Cell Transplantation and Validation
07:16

Organotypic Cultures of Adult Human Cortex as an Ex vivo Model for Human Stem Cell Transplantation and Validation

Published on: December 9, 2022

Anteromesial Temporal Lobectomy for Medically Intractable Temporal Lobe Epilepsy: An Operative Study
11:29

Anteromesial Temporal Lobectomy for Medically Intractable Temporal Lobe Epilepsy: An Operative Study

Published on: August 15, 2025

Promotion of Survival and Differentiation of Neural Stem Cells with Fibrin and Growth Factor Cocktails after Severe Spinal Cord Injury
09:56

Promotion of Survival and Differentiation of Neural Stem Cells with Fibrin and Growth Factor Cocktails after Severe Spinal Cord Injury

Published on: July 27, 2014

Area of Science:

  • Neuroscience
  • Regenerative Medicine
  • Epilepsy Research

Background:

  • Temporal lobe epilepsy (TLE) affects ~30% of epilepsy patients, often causing cognitive issues and drug resistance in ~35%.
  • Hippocampal resection, a common TLE treatment, can lead to cognitive deficits and drug dependence.
  • Alternative therapies are needed to control seizures and reverse cognitive dysfunction in TLE.

Purpose of the Study:

  • To review the progress and prospects of cell transplantation as a therapy for TLE.
  • To evaluate different donor cell types for seizure suppression and cognitive improvement.
  • To identify mechanisms and strategies for enhancing cell-based TLE treatments.

Main Methods:

  • Review of existing literature on cell transplantation for TLE.
  • Discussion of studies using various donor cells (hippocampal precursors, GABAergic progenitors, neural stem cells).
  • Emphasis on long-term electroencephalographic monitoring and mechanistic studies in animal models.

Main Results:

  • Cell transplantation can potentially curtail epileptogenesis and restrain spontaneous seizures.
  • This approach may improve cognitive function in TLE models.
  • Further research is required to optimize cell types and grafting strategies.

Conclusions:

  • Cell transplantation is a promising alternative therapy for TLE, offering both anti-seizure and pro-cognitive effects.
  • Rigorous evaluation in chronic TLE animal models is essential for clinical translation.
  • Understanding graft-mediated mechanisms and refining delivery methods are key future directions.